Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents

OBJECTIVE: To evaluate efficacy and safety of switching from twice-daily exenatide to once-daily liraglutide or of 40 weeks of continuous liraglutide therapy. RESEARCH DESIGN AND METHODS: When added to oral antidiabetes drugs in a 26-week randomized trial (Liraglutide Effect and Action in Diabetes [...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Buse, John B., Sesti, Giorgio, Schmidt, Wolfgang E., Montanya, Eduard, Chang, Cheng-Tao, Xu, Yizhen, Blonde, Lawrence, Rosenstock, Julio
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Diabetes Association 2010
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875443/
https://ncbi.nlm.nih.gov/pubmed/20332351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-2260
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk